Trevi Therapeutics
TRVI
#4558
Rank
NZ$4.28 B
Marketcap
NZ$30.11
Share price
-0.17%
Change (1 day)
137.84%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -NZ$80.91 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$73.83 Million, an increase over its 2024 earnings that were of -NZ$80.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$80.91 Million9.59%
2025 -NZ$73.83 Million-8.34%
2024 -NZ$80.55 Million67%
2023 -NZ$48.24 Million2.43%
2022 -NZ$47.09 Million-14.45%
2021 -NZ$55.05 Million1.36%
2020 -NZ$54.31 Million23.64%
2019 -NZ$43.93 Million27.54%
2018 -NZ$34.44 Million